Artificial intelligence (AI) is set to revolutionize cardiology, offering transformative advancements in diagnosis, treatment, and patient outcomes.1 Howev
AbstractCardiovascular disease is common in patients with prostate cancer and is a significant cause of death. Cardiovascular risk factors are frequent in this population and…
AbstractEpilepsy is an important cause of disability and mortality worldwide. It can be frequently misdiagnosed, and detailed history and relevant investigations are needed to differentiate…
Implementing and tracking quality improvement (QI) metrics may lead to improved outcomes in patient care after STEMI in low- and middle-income countries (LMIC), according to…
Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, The Netherlands Heart Center, Department of Clinical and Experimental Cardiology,…
The findings underscore the message that “it’s never too early to think about your heart health.”
Click on the article title to read more.
This small study suggests there’s much still to learn about how best to handle the complexity of repeat procedures.
Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease worldwide, affecting one-fourth of the world’s population. With more than half of…
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
À l’occasion de ses traditionnels vœux à la Curie, samedi 21 décembre 2024, François a critiqué le non-respect selon lui des règles de la guerre…
